SCHEMBL28653258

SCHEMBL28653258

CCOC(=O)C(C)C1CCN(C)C(C)C1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ACE P12821 1/20 0.34
TP53 P04637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CHRM1 P11229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14431954 0.76 L3MBTL1 (0.41) ALDH1A1L3MBTL1MAPTGAAKDM4E
SCHEMBL4680121 0.75 L3MBTL1 (0.46) ALDH1A1TRPM8L3MBTL1MAPTGAA
SCHEMBL28146922 0.74 ALDH1A1 (0.41) ALDH1A1L3MBTL1MAPTGAACYP3A4
SCHEMBL18044506 0.73 TRPM8 (0.37) ALDH1A1TRPM8L3MBTL1KDM4ESMN1; SMN2
SCHEMBL15123996 0.72 L3MBTL1 (0.38) ALDH1A1TRPM8L3MBTL1MAPTCYP2D6
SCHEMBL16530180 0.72 MAPT (0.44) ALDH1A1L3MBTL1MAPTGAAKDM4E
SCHEMBL1600214 0.72
SCHEMBL2648204 0.72 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4ECYP2D6
SCHEMBL31547036 0.72 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4ECYP2D6
Hydrochloric Acid SCHEMBL28582482 0.72 SLC6A2 (0.38) ALDH1A1TRPM8L3MBTL1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108699032-B Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2022-07-22 CN disclosed
CN-113603675-A Polycyclic TLR7/8 antagonists and their use in the treatment of immune disorders 默克专利有限公司 2021-11-05 CN disclosed